Skip to main content
Log in

Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater

  • Research Article
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

In this study, the enteric-coated delayed-release pellets of duloxetine hydrochloride (DLX) were formulated using a fluidized bed coater. Three separate layers, the drug layer, the barrier layer, and the enteric layer, were coated onto inert core pellets. Among the three formulations (F1–F3), the dissolution profiles of formulation F2 were most similar to those of the marketed product, with similarity and difference factors of 83.99 and 3.77, respectively. In addition, pharmacokinetic parameters of AUC, Cmax, Tmax, t1/2, Kel, and MRT of DLX for the developed formulation (F2) did not differ significantly from those for the marketed product in beagle dogs, suggesting that they were bioequivalent. Our results demonstrated that the in vitro dissolution data resembled the in vivo performance of the drug. Therefore, this study has a positive scope for further scale up and development of the formulation for achievement of the generic product.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abdul, S., A.V. Chandewar, and S.B. Jaiswal. 2010. A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS). Journal of Controlled Release 147: 2–16.

    Article  CAS  PubMed  Google Scholar 

  • Bymaster, F.P., L.J. Dreshfield-Ahmad, P.G. Threlkeld, J.L. Shaw, L. Thompson, D.L. Nelson, S.K. Hemrick-Luecke, and D.T. Wong. 2001. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25: 871–880.

    Article  CAS  PubMed  Google Scholar 

  • Cao, Q.R., J.S. Choi, Y. Liu, W.J. Xu, M. Yang, B.J. Lee, and J.H. Cui. 2013. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation. Drug Development and Industrial Pharmacy 39: 1720–1730.

    Article  CAS  PubMed  Google Scholar 

  • Chatlapalli, R., and B.D. Rohera. 1998. Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. International Journal of Pharmaceutics 161: 179–193.

    Article  CAS  Google Scholar 

  • Choi, H., Y. Oh, and C. Kim. 1998. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. International Journal of Pharmaceutics 165: 23–32.

    Article  CAS  Google Scholar 

  • Costa, P., J.M. Sousa Lobo, M.C. Gohel, and M.K. Panchal. 2001. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 13: 123–133.

    Article  CAS  PubMed  Google Scholar 

  • Costa, P., and J.M. Sousa Lobo. 2001. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Development and Industrial Pharmacy 27: 811–817.

    Article  CAS  Google Scholar 

  • Fishbain, D.A., J. Hall, A.L. Meyers, J. Gonzales, and C. Mallinckrodt. 2008. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from the studies for management of diabetic peripheral neuropathic pain with duloxetine. Journal of Pain and Symptom Management 36: 639–647.

    Article  CAS  PubMed  Google Scholar 

  • Frohoff-Hulsmann, M.A., B.C. Lippold, and J.W. McGinity. 1999. Aqueous ethyl cellulose dispersion containing plasticizers of different water solubility and hydroxy propyl methyl-cellulose as coating material for diffusion pellets II: properties of sprayed films. European Journal of Pharmaceutics and Biopharmaceutics 48: 67–75.

    Article  CAS  PubMed  Google Scholar 

  • Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. New York: Marcel Dekker.

    Google Scholar 

  • Goldstein, D.J., Y. Lu, M.J. Detke, C. Wiltse, C. Mallinckrodt, and M.A. Demitrack. 2004. Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine. Journal of Clinical Psychopharmacology 24: 389–399.

    Article  CAS  PubMed  Google Scholar 

  • Goyanes, A., and R. Martinez-Pacheco. 2013. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization. Drug Development and Industrial Pharmacy (Early online:1–7).

  • Hausner, H.H. 1967. Friction conditions in a mass of metal powder. International Journal of Powder Metallurgy 3: 7–13.

    Google Scholar 

  • International Conference on Harmonization (ICH Q2A, Q2B), 1995. Guidelines on validation of analytical procedures.

  • Jansen, P.J., P.L. Oren, C.A. Kemp, S.R. Maple, and S.W. Beartschi. 1998. Characterization of impurities formed by interaction of duloxetine HCl with enteric polymers hydroxypropyl methylcellulose acetate duccinate and hydroxypropyl methylcellulose phthalate. Journal of Pharmaceutical Sciences 87: 81–85.

    Article  CAS  PubMed  Google Scholar 

  • Korakianiti, E.S., D.M. Rekkas, P.P. Dallas, and N.H. Choulis. 2000. Optimization of the pelletization process in a fluid- bed rotor granulator using experimental design. AAPS Pharm SciTech 1: 71–75.

    Article  Google Scholar 

  • Lecomte, F., J. Siepmann, M. Walther, R.J. MacRae, and R. Bodmeier. 2004. Polymer blends used for the coating of multiparticulates: Comparison of aqueous and organic coating techniques. Pharmaceutical Research 21: 882–890.

    Article  CAS  PubMed  Google Scholar 

  • Mastan, S., T.B. Latha, and S. Ajay. 2011. The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies—An overview. Comparative Effectiveness Research 1: 1–25.

    Article  Google Scholar 

  • Mease, P.J., I.J. Russell, D.K. Kajdasz, C.G. Wiltse, M.J. Detke, M.M. Wohlreich, D.J. Walker, and A.S. Chappell. 2010. Long term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Seminars in Arthritis and Rheumatism 39: 454–464.

    Article  CAS  PubMed  Google Scholar 

  • Mohamed, F.A., M. Roberts, L. Seton, J.L. Ford, M. Levina, and A.R. Rajabi-Siahboomi. 2013. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets. Drug Development and Industrial Pharmacy 38: 1167–1174.

    Article  Google Scholar 

  • Robinson, D., and L. Cardozo. 2010. New drug treatments for urinary incontinence. Maturitas 65: 340–347.

    Article  CAS  PubMed  Google Scholar 

  • Sharma, A., M.J. Goldberg, and B.J. Cerimele. 2000. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. The Journal of Clinical Pharmacology 40: 161–167.

    Article  CAS  PubMed  Google Scholar 

  • Shravani, D., P.K. Lakshmi, and J. Balasubramaniam. 2011. Preparation and optimization of various parameters of enteric coated pellets using the Taguchi L9 orthogonal array design and their characterization. Acta Pharmaceutica Sinica B 1: 56–63.

    Article  CAS  Google Scholar 

  • Sinha, V.R., R. Kumria, and J.R. Bhinge. 2009. Stress degradation studies on duloxetine hydrochloride and development of an RP-HPLC method for its determination in capsule formulation. Journal of Chromatographic Science 47: 589–593.

    Article  CAS  PubMed  Google Scholar 

  • Valizadeh, H., P. Nayyeri-Maleki, S. Ghanbarzadeh, A. Sheikhloo, H. Servat, M. Nemati, and P. Zakeri-Milani. 2014. Pharmacokinetics and bioequivalence of two brands of metformin 500 mg tablets in Iranian healthy volunteers. Journal of Pharmaceutical Investigation 44: 61–68.

    Article  CAS  Google Scholar 

  • Westanmo, A.D., J. Gayken, and R. Haight. 2005. Duloxetine: A balanced and selective norepinephrine-and serotonin-reuptake inhibitor. American Journal of Health-System Pharmacy 62: 2481–2490.

    Article  CAS  PubMed  Google Scholar 

  • Yong, C.S., D.X. Li, D.H. Oh, J.A. Kim, B.K. Yoo, J.S. Woo, J.D. Rhee, and H.G. Choi. 2005. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaraldehyde. Archives of Pharmacal Research 29: 431–534.

    Google Scholar 

  • Yuksel, N., A.E. Kanik, and T. Baykara. 2000. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and independent methods. International Journal of Pharmaceutics 209: 57–67.

    Article  CAS  PubMed  Google Scholar 

  • Zhao, R.K., G. Cheng, J. Tang, J. Song, and W.X. Peng. 2009. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study. Clinical Therapeutics 31: 1022–1036.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Medical Cluster R&D Support Project of Daegu Gyeongbuk Medical Innovation Foundation, Republic of Korea (2013) (No. HT13C0011).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ho Taek Im or Jong Oh Kim.

Additional information

Yong-Il Kim and Roshan Pradhan contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, YI., Pradhan, R., Paudel, B.K. et al. Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater. Arch. Pharm. Res. 38, 2163–2171 (2015). https://doi.org/10.1007/s12272-015-0590-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-015-0590-y

Keywords

Navigation